[1]Mazur MT, Clark HB.Gastric stromal tumors: Reappraisal of histogenesis[J].Am J Surg Patho,1983,7:507-519[2]Hirota S, Isozaki K, Moriyama Y, et al.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors[J].Science,1998,279:577-580[3]Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al.CD117: a sensitive marker forgastrointestinal stromal tumors that is more specific than CD34[J].Mod Pathol,1998,11:728-734[4]Tran T, Davila JA, El-Serag HB.The epidemiology of malignant gastrointestinal stromal tumors:an analysis of 1,458 cases from 1992 to 2000[J].Am J Gastroenterol,2005,100:162-168[5]Miettinen M, Sobin LH, Lasota J.Gastrointestinal stromaltumors of the stomach a clinicopathologic, immunohisto-chemical, and molecular genetic study of 1765 cases with long-term follow-up[J].Am J Surg Pathol,2005,29(1):52-68[6]张海军, 张晶.胃肠道间质瘤CT和MRI诊断及价值[J].中华现代医药杂志,2006,8 (11):67-69[7]孙灿辉, 李子平, 孟悛非, 等.CT和超声内镜诊断胃肠道间质瘤的价值分析[J].中华放射学杂志,2004,38:197-201[8]Boggino HE, Fernandez MP, Logrono R.Cytomorphology of gastrointestinal stromal tumor: diagnostic role of aspiration cytology, corebiopsy, and immunochemistry[J].Diagn cytopathol,2000,23(3):156-160[9]胃肠道间质瘤中国专家组.胃肠道间质瘤诊断与治疗中国专家共识[J]. 中华胃肠外科杂志, 2009年第5[10]Dimhofer S, Zimpfer A, Went P.The diagnostic and predietive role of kit (CDll7)[J].Ther Umsch,2006,63(4):273-278[11]Natkunam Y, Rouse RV, Zhu S, et al.Immunobolt analysis of CD34 expression in histologically diverse neoplasms[J].Am J Pathol,2000,156(1):21-27[12]Joensuu H.Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J].Hum Pathol,2008,39:1411-1419 |